Market Overview

Benzinga's Top Downgrades

Benzinga's Top Downgrades
Related ESRX
Express Scripts Downgraded On Fear It Could Lose Anthem Contract
Express Scripts Confirms It's Working With Sen. Wyden's Bill
American College Of Cardiology: No Repatha Of Glory (Seeking Alpha)

Analysts at Goldman Sachs downgraded Express Scripts Holding Company (NASDAQ: ESRX) from Buy to Neutral. The target price for Express Scripts is set to $75. Express Scripts' shares closed at $75.05 yesterday.

Northland Securities downgraded E2open Inc (NASDAQ: EOPN) from Outperform to Market Perform. The target price for E2open has been lowered from $27 to $16. E2open's shares closed at $15.61 yesterday.

Analysts at Buckingham Research downgraded Crocs, Inc. (NASDAQ: CROX) from Buy to Neutral. Crocs' shares closed at $15.04 yesterday.

Analysts at Needham downgraded E2open (NASDAQ: EOPN) from Outperform to Market Perform and removed the target price of $24. E2open's shares closed at $15.61 yesterday.

Latest Ratings for ESRX

Mar 2017Wells FargoDowngradesMarket PerformUnderperform
Nov 2016Deutsche BankUpgradesSellHold
Oct 2016UBSInitiates Coverage onNeutral

View More Analyst Ratings for ESRX
View the Latest Analyst Ratings

Posted-In: Top DowngradesDowngrades Analyst Ratings


Related Articles (CROX + EOPN)

View Comments and Join the Discussion!